Back To: Home

Our 2017 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
October 2016
Will embracing complexity lead to safer drugs?...
by Randall C Willis
October 2016
F-star and Denali to develop multispecific antibody platform for crossing blood-brain barrier...
by Mel J. Yeates
October 2016
Bioclinica acquisition deal marks the first investment with the Sixth Cinven Fund...
by Kelsey Kaustinen
October 2016
Recent study results for Toujeo and Dupixent mark two clinical trial successes this fall...
by Jeffrey Bouley
Top Story
Show Preview:
46th Annual Meeting of the Society for Neuroscience
November 12-16, 2016
San Diego Convention Center

Editor's Focus:
October 2016
In efforts to improve upon the human relevance of mouse-based studies, investigators are increasingly turning to models with genetically introduced human components.. [ more ]
by Michael Seiler of Taconic

October 2016
Thanks to a lack of appropriate trials, pharma, healthcare professionals, government, educators, caring/hopeful parents and others are forced to wing it with drugs not fully vetted in the pediatric population.. [ more ]
by Peter T. Kissinger

October 2016
Where does the target market for drugs intersect with regard to humans and animals...and should it?.. [ more ]
by Jeffrey Bouley

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2016 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.